ELIZABETH YAROTSKY: Open Payments
NPI 1275807265 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$558 in 17 payments from 8 companies in 2025. Trend: 2023 $413 · 2024 $718 · 2025 $558
Food & beverage: $458Education: $100
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 6 | $192 |
| SANOFI-AVENTIS U.S. LLC | 1 | $100 |
| GENZYME CORPORATION | 3 | $88 |
| Optinose US, Inc. | 2 | $57 |
| AERIN MEDICAL INC. | 2 | $41 |
| Smith+Nephew, Inc. | 1 | $38 |
| Merck Sharp & Dohme LLC | 1 | $25 |
| Hikma Pharmaceuticals USA | 1 | $17 |
Products named: DUPIXENT, Xhance, VIVAER STYLUS, KEYTRUDA QLEX, Ryaltris.
Industry payments across TX — which companies pay providers there.
